News

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
Business Wire1mon
Verge Genomics and Collaborators Identify Digital Clinical Biomarker Endpoints Sensitive to Short Term Disease Progression in the Pre-treatment Run-in Period of VRG50635 Proof ...
Enrollment in the Phase 1b proof-of-concept Study of VRG50635 for treatment of ALS was completed in August of 2024, and the study is on track to deliver efficacy and safety results in the second ...